JPH0128043B2 - - Google Patents
Info
- Publication number
- JPH0128043B2 JPH0128043B2 JP13967280A JP13967280A JPH0128043B2 JP H0128043 B2 JPH0128043 B2 JP H0128043B2 JP 13967280 A JP13967280 A JP 13967280A JP 13967280 A JP13967280 A JP 13967280A JP H0128043 B2 JPH0128043 B2 JP H0128043B2
- Authority
- JP
- Japan
- Prior art keywords
- acidic
- coating
- cellulose
- succinoyl
- phthaloyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000002378 acidificating effect Effects 0.000 claims description 18
- 229920003086 cellulose ether Polymers 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 12
- -1 succinoyl groups Chemical group 0.000 claims description 12
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 claims description 9
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- 238000000576 coating method Methods 0.000 description 22
- 239000011248 coating agent Substances 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 239000007788 liquid Substances 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- 239000002775 capsule Substances 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000005886 esterification reaction Methods 0.000 description 6
- 229920000609 methyl cellulose Polymers 0.000 description 6
- 239000001923 methylcellulose Substances 0.000 description 6
- 235000010981 methylcellulose Nutrition 0.000 description 6
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 6
- 239000004014 plasticizer Substances 0.000 description 6
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 5
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229940014800 succinic anhydride Drugs 0.000 description 4
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- IYKJEILNJZQJPU-UHFFFAOYSA-N acetic acid;butanedioic acid Chemical compound CC(O)=O.OC(=O)CCC(O)=O IYKJEILNJZQJPU-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000008065 acid anhydrides Chemical class 0.000 description 3
- 229920013820 alkyl cellulose Polymers 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002301 cellulose acetate Polymers 0.000 description 3
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002702 enteric coating Substances 0.000 description 3
- 238000009505 enteric coating Methods 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 3
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000002662 enteric coated tablet Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 2
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- VKEQBMCRQDSRET-UHFFFAOYSA-N Methylone Chemical compound CNC(C)C(=O)C1=CC=C2OCOC2=C1 VKEQBMCRQDSRET-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000003900 succinic acid esters Chemical class 0.000 description 1
Description
本発明は、新規化合物である、セルロースエー
テルの酸性サクシノイルおよび酸性フタロイル混
成エステルに関するものである。
従来、セルロースまたはセルロースエーテルの
カルボン酸エステルとしては、セルロースアセテ
ートフタレート、セルロースアセテートサクシネ
ート、メチルセルロースフタレート、ヒドロキシ
プロピルメチルセルロースフタレート、メチルセ
ルロースサクシネート、ヒドロキシプロピルメチ
ルセルロースサクシネートなどが知られており、
これらは腸溶性コーテイング剤等として応用され
ている。
しかしながら、上記したもののうちセルロース
アセテートフタレートおよびセルロースアセテー
トサクシネートは、水分の作用によつて徐々に分
解して酢酸、フタル酸あるいはコハク酸を遊離し
やすく、腸液に対する溶解性が次第に低下すると
いう欠点がある。また、メチルセルロースフタレ
ートおよびヒドロキシプロピルメチルセルロース
フタレートは、腸液に対する溶解時間が長すぎた
り、あるいは被膜とした場合に柔軟性に劣るた
め、被覆剤として応用するにあたつては多量の可
塑剤を併用する必要があるが、このような可塑剤
の使用は柔軟性に富む被膜を形成する反面、後に
この可塑剤が被膜表面に移行したり、また表面か
ら徐徐に揮発したりするなどのおそれがあり、し
たがつて腸溶性コーテイング剤等として応用した
場合には医薬に悪影響を与えることも懸念され、
また被膜の物性が経時的に変化するという欠点が
ある。
さらに、メチルセルロースサクシネートおよび
ヒドロキシプロピルメチルセルロースサクシネー
トは、これらが柔軟性に富む被膜を形成するので
可塑剤を使用する必要はないが、その反面、これ
らのサクシネート類の被覆膜は互いに付着しやす
く、またベタつきやすいという重大な欠点があ
る。
本発明はこのような欠点のない新規化合物を提
供しようとするもので、これは炭素数1〜3のア
ルキル基および/または炭素数2〜4のヒドロキ
シアルキル基で置換されたセルロースエーテル
の、グリコース単位1個当りの酸性サクシノイル
基および酸性フタロイル基の平均置換数がそれぞ
れ0.1〜2.0で、重量平均分子量が10000〜300000
である、酸性サクシノイルおよび酸性フタロイル
混成エステルに関するものである。
上記セルロースエーテルの混成エステルは、(1)
可塑剤をほとんど必要とせずに柔軟性に富む強じ
んな被膜を形成する、(2)被覆膜とした場合に膜表
面のベタつきがなくそれが互いに付着するという
ようなことがない、(3)保存中に湿気により変質す
るなど経時的な化学的、物理的変化を起こすこと
がない、など種々の利点を有するもので、特には
腸溶性被覆錠剤の製造に好適に使用されるもので
ある。
以下、本発明を詳しく説明する。
上記セルロースエーテルの酸性サクシノイルす
なわち式
で示される基と酸性フタロイルすなわち一般式
で示される基との混成エステルは、グルコース単
位1個当りの酸性サクシノイル基および酸性フタ
ロイル基の平均置換数がそれぞれ0.1〜2.0で、重
量平均分子量が10000〜300000のもので、セルロ
ースエーテルに無水コハク酸と無水フタル酸とを
エステル化反応させて得られるものである。この
混成エステルの重量平均分子量が上記の範囲より
も大きいときは、被覆錠剤を製造する際の有機溶
剤溶液の粘性が高くなり過ぎて取扱いにくくなつ
たり、その粘性を低下させるために多量の溶剤を
必要とするようになり、またこの範囲より小さい
ときは、高分子としての性質が失われ被覆膜が脆
くなるという不利が生ずる。このセルロースエー
テルとしては炭素数1〜3のアルキル基および/
または炭素数2〜4のヒドロキシアルキル基で置
換されたものであることが必要とされ、これには
メチルセルロース、エチルセルロース、プロピル
セルロースなどのアルキルセルロース、ヒドロキ
シエチルセルロース、ヒドロキシプロピルセルロ
ース、ヒドロキシブチルセルロースなどのヒドロ
キシアルキルセルロース、およびヒドロキシエチ
ルメチルセルロース、ヒドロキシエチルエチルセ
ルロース、ヒドロキシプロピルメチルセルロー
ス、ヒドロキシプロピルエチルセルロース、ヒド
ロキシブチルメチルセルロース、ヒドロキシブチ
ルエチルセルロースなどのヒドロキシアルキルア
ルキルセルロース、さらにはヒドロキシエチルヒ
ドロキシプロピルメチルセルロースなどが例示さ
れる。
これらのセルロースエーテルの重量平均分子量
は、これから得られる混成エステルの重量平均分
子量を10000〜300000とするために、概ね7000〜
250000であることが必要とされ、その置換基のモ
ル数は特に制限はないが、一般にはアルキルセル
ロースおよびヒドロキシアルキルアルキルセルロ
ースの場合アルキル基の置換分子数がグルコース
単位当り2.5よりも大きくなると、前記した酸無
水物とのエステル化反応が困難になるので、これ
以下であることが望ましい。
上記セルロースエーテルとエステル化反応させ
る無水コハク酸および無水フタル酸としては一般
に市販されているものを使用すればよく、エステ
ル化反応は酢酸、プロピオン酸、らく酸等のカル
ボン酸を反応媒体として使用し、酢酸ナトリウ
ム、酢酸カリウム等のカルボン酸のアルカリ金属
塩(触媒)の存在下に、セルロースエーテルと無
水コハク酸および無水フタル酸とをエステル化反
応させる方法、あるいはアセトン、ジメチルホル
ムアミドなどの適当な溶媒中でピリジン、α−ピ
コリン等の塩基性触媒の存在下にセルロースエー
テルと無水コハク酸および無水フタル酸とをエス
テル化反応させる方法によればよい。
なお、2種の酸無水物の反応器への仕込みは同
時に行つてもよく、またいずれか一方を先に仕込
んで反応させ、つぎに他方を仕込んで反応させる
方法によつてもよい。
エステル化反応終了後は反応液に多量の水を加
えて反応生成物(混成エステル)を析出させ、水
で十分に洗浄して精製した後、乾燥させることに
より粉粒状の高純度の製品が得られる。
このような混成エステルからは柔軟性に富む強
じんな被膜が得られ、これは人工腸液や写真現像
液のようなアルカリ性液体に速やかに溶解する性
質を示す。
したがつて、本発明のセルロースエーテルの酸
性サクシノイルおよび酸性フタロイル混成エステ
ルは、水または有機溶剤に分散または溶解して被
覆液としこれを用いて錠剤、丸剤、顆粒剤、カプ
セル剤等を被覆することにより腸溶性医薬品を製
造することができる。この場合の有機溶剤として
はアセトン、塩化メチレン、酢酸エチル、1,
1,1−トリクロロエタン、メチルアルコール、
エチルアルコールなどの1種もしくは2種以上の
混合溶剤が使用される。なお、被覆液には各種の
添加剤たとえば着色剤、きよう味きよう臭剤、香
料、可塑剤等を配合してもよい。なお、被覆手段
としてはパンコーテイング装置、ドラムタイプコ
ーテイング装置あるいは流動コーテイング装置等
の装置を使用する従来公知の方法によればよく、
被覆操作自体に特別の制限はない。
他方また本発明のセルロース混成エステルから
カプセルを製造することもできる。この方法とし
ては前記した被覆液に成型ピンを浸漬し引き上げ
て乾燥する浸漬法、あるいは一たんフイルムない
しシート材としついでこれを加熱加圧成形する成
形法等によればよい。
つぎに具体的実施例をあげる。
実施例
かくはん機付反応容器に、氷酢酸100重量部、
酢酸ナトリウム20重量部および表−1に示す種
類、量のセルロースエーテル、無水コハク酸、無
水フタル酸をそれぞれ仕込み、85℃で3時間エス
テル化反応させた。
つぎに、反応液に水を加えて反応生成物を析出
させ、水洗後乾燥したところ、表−1に示すとお
りの酸性サクシノイル基および酸性フタロイル基
を有する混成エステルが得られた。ただし、表−
1中で用いた略記号は下記のとおりである。
MC:メチルセルロース、グルコース単位あ
たりのメトキシ基置換モル数1.80。
HPMC:ヒドロキシプロピルメチルセルロー
ス、グルコース単位あたりのヒドロキシプロポ
キシル基置換モル数0.27、メトキシ基置換モル
数1.82。
HPC:ヒドロキシプロピルセルロース、グル
コース単位あたりのヒドロキシプロポキシル基
置換モル数3.00。
DS:グルコース単位あたりの置換基のモル
数。
The present invention relates to novel compounds, acidic succinoyl and acidic phthaloyl mixed esters of cellulose ethers. Conventionally, cellulose acetate phthalate, cellulose acetate succinate, methyl cellulose phthalate, hydroxypropyl methyl cellulose phthalate, methyl cellulose succinate, hydroxypropyl methyl cellulose succinate, etc. are known as carboxylic acid esters of cellulose or cellulose ether.
These are applied as enteric coating agents and the like. However, among the above-mentioned cellulose acetate phthalate and cellulose acetate succinate, cellulose acetate phthalate and cellulose acetate succinate have the disadvantage that they tend to gradually decompose under the action of water and release acetic acid, phthalic acid, or succinic acid, and their solubility in intestinal fluids gradually decreases. be. In addition, methylcellulose phthalate and hydroxypropyl methylcellulose phthalate take too long to dissolve in intestinal fluid, or have poor flexibility when formed into a coating, so it is necessary to use a large amount of plasticizer when used as a coating. However, while the use of such plasticizers forms a highly flexible film, there is a risk that the plasticizers may later migrate to the film surface or gradually volatilize from the surface. There are concerns that it may have an adverse effect on medicines if it is applied as an enteric coating agent, etc.
Another drawback is that the physical properties of the coating change over time. Additionally, methylcellulose succinate and hydroxypropyl methylcellulose succinate form flexible films that do not require the use of plasticizers; however, the coatings of these succinates tend to stick to each other. , it also has a serious drawback of being easily sticky. The present invention aims to provide a novel compound free from such drawbacks, which is a glycose ether of cellulose ether substituted with an alkyl group having 1 to 3 carbon atoms and/or a hydroxyalkyl group having 2 to 4 carbon atoms. The average number of substitutions of acidic succinoyl groups and acidic phthaloyl groups per unit is 0.1 to 2.0, respectively, and the weight average molecular weight is 10,000 to 300,000.
The invention relates to acidic succinoyl and acidic phthaloyl mixed esters. The above hybrid ester of cellulose ether is (1)
Forms a highly flexible and strong film with almost no need for plasticizer; (2) When used as a coating film, the film surface is not sticky and does not stick to each other; (3) ) It has various advantages such as not undergoing chemical or physical changes over time such as deterioration due to moisture during storage, and is especially suitable for use in the production of enteric coated tablets. . The present invention will be explained in detail below. Acidic succinoyl of the above cellulose ether i.e. formula The group represented by and acidic phthaloyl, that is, the general formula A hybrid ester with a group represented by the above has an average number of substitutions of acidic succinoyl group and acidic phthaloyl group per glucose unit of 0.1 to 2.0, respectively, and a weight average molecular weight of 10,000 to 300,000. It is obtained by esterifying an acid and phthalic anhydride. When the weight average molecular weight of this mixed ester is larger than the above range, the viscosity of the organic solvent solution used to manufacture coated tablets may become too high and become difficult to handle, or a large amount of solvent may be used to reduce the viscosity. If the amount is smaller than this range, the polymeric properties will be lost and the coating film will become brittle. This cellulose ether includes an alkyl group having 1 to 3 carbon atoms and/or
or substituted with a hydroxyalkyl group having 2 to 4 carbon atoms, including alkylcelluloses such as methylcellulose, ethylcellulose, and propylcellulose; Examples include alkylcellulose, hydroxyalkylalkylcellulose such as hydroxyethylmethylcellulose, hydroxyethylethylcellulose, hydroxypropylmethylcellulose, hydroxypropylethylcellulose, hydroxybutylmethylcellulose, and hydroxybutylethylcellulose, and further hydroxyethylhydroxypropylmethylcellulose. The weight average molecular weight of these cellulose ethers is approximately 7,000 to 7,000 in order to make the weight average molecular weight of the resulting hybrid ester 10,000 to 300,000.
250,000, and the number of moles of the substituents is not particularly limited, but generally in the case of alkyl cellulose and hydroxyalkylalkyl cellulose, when the number of molecules substituted by the alkyl group is larger than 2.5 per glucose unit, the above-mentioned Since the esterification reaction with the acid anhydride becomes difficult, it is desirable that the amount is less than this. Generally commercially available succinic anhydride and phthalic anhydride to be used in the esterification reaction with the cellulose ether may be used. In the esterification reaction, a carboxylic acid such as acetic acid, propionic acid, or laconic acid may be used as the reaction medium. , a method of esterifying cellulose ether with succinic anhydride and phthalic anhydride in the presence of an alkali metal salt (catalyst) of a carboxylic acid such as sodium acetate or potassium acetate, or a suitable solvent such as acetone or dimethylformamide. Among them, a method may be used in which cellulose ether is subjected to an esterification reaction with succinic anhydride and phthalic anhydride in the presence of a basic catalyst such as pyridine or α-picoline. Note that the two types of acid anhydrides may be charged into the reactor at the same time, or one of them may be charged first and reacted, and then the other may be charged and reacted. After the esterification reaction is complete, a large amount of water is added to the reaction solution to precipitate the reaction product (mixed ester), which is thoroughly washed with water for purification and then dried to obtain a powdery, highly pure product. It will be done. Such mixed esters provide flexible and strong coatings that are readily soluble in alkaline liquids such as artificial intestinal fluid and photographic developers. Therefore, the acidic succinoyl and acidic phthaloyl mixed ester of cellulose ether of the present invention can be dispersed or dissolved in water or an organic solvent to form a coating liquid, which is used to coat tablets, pills, granules, capsules, etc. Enteric-coated pharmaceuticals can be manufactured by this method. In this case, the organic solvents include acetone, methylene chloride, ethyl acetate, 1,
1,1-trichloroethane, methyl alcohol,
One or more mixed solvents such as ethyl alcohol are used. Incidentally, various additives such as colorants, taste and odor agents, fragrances, plasticizers, etc. may be added to the coating liquid. The coating means may be a conventionally known method using a pan coating device, a drum type coating device, a fluid coating device, or the like.
There are no particular restrictions on the coating operation itself. On the other hand, it is also possible to produce capsules from the cellulose hybrid esters of the invention. This may be accomplished by a dipping method in which a molding pin is immersed in the coating liquid, pulled up and dried, or a molding method in which a film or sheet material is formed and then heated and pressure molded. Next, specific examples will be given. Example In a reaction vessel equipped with a stirrer, 100 parts by weight of glacial acetic acid,
20 parts by weight of sodium acetate, cellulose ether, succinic anhydride, and phthalic anhydride in the types and amounts shown in Table 1 were charged, and an esterification reaction was carried out at 85°C for 3 hours. Next, water was added to the reaction solution to precipitate the reaction product, which was washed with water and then dried to obtain a mixed ester having an acidic succinoyl group and an acidic phthaloyl group as shown in Table 1. However, table -
The abbreviations used in 1 are as follows. MC: Methylcellulose, number of moles of methoxy group substitution per glucose unit: 1.80. HPMC: Hydroxypropyl methylcellulose, number of moles substituted with hydroxypropoxy group per glucose unit: 0.27, number of moles substituted with methoxy group: 1.82. HPC: Hydroxypropylcellulose, 3.00 moles of hydroxypropoxyl group substitution per glucose unit. DS: moles of substituents per glucose unit.
【表】【table】
(1) 有機溶媒に対する溶解性:
サンプル1gに有機溶媒9gを加え、室温に
て観察し溶解したものを〇、膨潤したものを
△、全く溶けないものを×として示した。
(2) 引張特性:
サンプルをアセトンに溶解し、キヤステイン
グによりフイルムを製造し、オートグラフIS−
5000(島津製作所製)を用いて測定した。
(3) 経時安定性:
サンプルを60℃、相対湿度100%の条件下2
週間放置した後、塩化メチレン/メタノール
(1:1)混合溶媒に溶解し、n−ヘキサンを
加えてから水にて抽出し、その一部をUV測定
することにより遊離のフタル酸量を決定した。
次いで残りを0.1N−NaOHにて滴定し全体の
遊離酸量を決定し、これと上記遊離フタル酸量
との差により遊離コハク酸量を求めた。
(4) 付着性:
前記(2)の方法で製造したフイルム試験片(20
×20×0.1mm)を2枚重ね荷重10g/cm2、温度
60℃、相対湿度81%の条件下で24時間圧着し、
フイルム同士が付着しているかどうかを調べ
た。
(1) Solubility in organic solvents: 9 g of organic solvent was added to 1 g of sample and observed at room temperature. Those that dissolved were indicated as ○, those that swelled were indicated as △, and those that did not dissolve at all were indicated as ×. (2) Tensile properties: Dissolve the sample in acetone, manufacture a film by casting, and autograph IS-
5000 (manufactured by Shimadzu Corporation). (3) Stability over time: Samples were stored at 60℃ and 100% relative humidity2.
After leaving it for a week, it was dissolved in a mixed solvent of methylene chloride/methanol (1:1), added with n-hexane, extracted with water, and a portion of it was subjected to UV measurement to determine the amount of free phthalic acid. .
Next, the remaining amount was titrated with 0.1N-NaOH to determine the total amount of free acid, and the amount of free succinic acid was determined from the difference between this and the above amount of free phthalic acid. (4) Adhesion: A film test piece (20
×20×0.1mm) stacked, load 10g/cm 2 , temperature
Pressed for 24 hours at 60℃ and 81% relative humidity.
I checked to see if the films were attached to each other.
被覆液温度 24℃
被覆液供給速度 30ml/分
乾燥空気温度 40℃
スプレー空気流量 100/分
被覆時間 180分
このようにして被覆することにより1錠当り約
20mgの被覆が施された腸溶性被覆錠剤を得た。こ
の被覆錠剤を第九改正日本薬局方による腸溶性製
剤に関する崩壊試験法にしたがつて試験を行つた
ところ、つぎのとおりであつた。
第1液に対する崩壊性:2時間以上変化なし
第2液に対する崩壊性:12〜14分で崩壊
(裸錠の崩壊時間は9〜10分であつた。)
被覆試験2
前記試料No.2のものを20重量%となるように
アセトンに溶解させ、室温にて放置して脱泡し、
均一な粘稠溶液を作つた。
この溶液中に、カプセルの半部分を製造するた
めの成型ピン(キヤツプ用およびボデイ用モール
ド)を浸漬し、ゆつくり引き上げてピンの周りに
粘稠な液の膜を形成させ、ついで充分に乾燥した
後ピンから成形体をはずし、必要な加工を施しカ
プセルを得た。このカプセルは透明で柔軟かつ強
じんなものであつた。
こうして得たカプセルに乳糖粉末を充てんし、
キヤツプとボデイのかん合部を本試験で作つた粘
稠溶液でシールした。この充てんカプセルについ
て第九改正日本薬局方に基づく崩壊試験器を用
い、第1液、第2液に対する溶解性を調べたとこ
ろ、結果はつぎのとおりであつた。
第1液に対する溶解性:2時間以上溶解せず
第2液に対する溶解性:15〜20分で溶解し内容物
放出
被覆試験3
前記試料No.3のものをアセトンに濃度10重量
%となるように溶解させ、実施例1における同様
の操作条件にて腸溶性被覆剤を得た。この被覆錠
剤を第九改正日本薬局方による腸溶性製剤に関す
る崩壊試験法にしたがつて試験を行つたところ、
結果はつぎのとおりであつた。
第1液に対する崩壊性:2時間以上変化なし
第2液に対する崩壊性:11〜12分で崩壊
(裸錠の崩壊時間は9〜10分であつた。)
Coating liquid temperature: 24°C Coating liquid supply rate: 30ml/min Drying air temperature: 40°C Spray air flow rate: 100/min Coating time: 180 min By coating in this way, each tablet can be coated with approx.
Enteric coated tablets with a coating of 20 mg were obtained. When this coated tablet was tested according to the disintegration test method for enteric-coated preparations according to the Ninth Edition Japanese Pharmacopoeia, the results were as follows. Disintegration property with the first liquid: No change for over 2 hours Disintegration property with the second liquid: Disintegrated in 12 to 14 minutes (Disintegration time of the bare tablet was 9 to 10 minutes.) Covering test 2 Sample No. 2 Dissolve the substance in acetone to a concentration of 20% by weight, leave it at room temperature to defoam,
A homogeneous viscous solution was created. A molding pin (cap and body mold) for manufacturing half of the capsule is immersed in this solution, slowly pulled up to form a viscous liquid film around the pin, and then thoroughly dried. After that, the molded body was removed from the pin and subjected to necessary processing to obtain a capsule. This capsule was transparent, flexible, and strong. The capsules thus obtained are filled with lactose powder,
The mating area between the cap and the body was sealed with a viscous solution prepared in this test. When this filled capsule was examined for solubility in the first and second liquids using a disintegration tester based on the Ninth Edition Japanese Pharmacopoeia, the results were as follows. Solubility in the first liquid: Does not dissolve for more than 2 hours Solubility in the second liquid: Dissolves in 15 to 20 minutes Content release coating test 3 Sample No. 3 was added to acetone to a concentration of 10% by weight. An enteric coating was obtained under the same operating conditions as in Example 1. When this coated tablet was tested according to the disintegration test method for enteric-coated preparations according to the Ninth Edition Japanese Pharmacopoeia,
The results were as follows. Disintegration in the first liquid: No change for over 2 hours Disintegration in the second liquid: Disintegrated in 11 to 12 minutes (Disintegration time of the bare tablet was 9 to 10 minutes).
図面は実施例の表−1中に示した試料No.2の
赤外線吸収スペクトルを示したものである。
The drawing shows the infrared absorption spectrum of sample No. 2 shown in Table 1 of Examples.
Claims (1)
素数2〜4のヒドロキシアルキル基で置換された
セルロースエーテルの、グルコース単位1個当り
の酸性サクシノイル基および酸性フタロイル基の
平均置換数がそれぞれ0.1〜2.0で、重量平均分子
量が10000〜300000である酸性サクシノイルおよ
び酸性フタロイル混成エステル。1 The average number of substitutions of acidic succinoyl groups and acidic phthaloyl groups per glucose unit of the cellulose ether substituted with an alkyl group having 1 to 3 carbon atoms and/or a hydroxyalkyl group having 2 to 4 carbon atoms is 0.1 to 0.1, respectively. 2.0, an acidic succinoyl and acidic phthaloyl mixed ester with a weight average molecular weight of 10,000 to 300,000.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13967280A JPS5763301A (en) | 1980-10-06 | 1980-10-06 | Cellulose ether acidic succinoyl and acidic phthaloyl mixed ester |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13967280A JPS5763301A (en) | 1980-10-06 | 1980-10-06 | Cellulose ether acidic succinoyl and acidic phthaloyl mixed ester |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5763301A JPS5763301A (en) | 1982-04-16 |
JPH0128043B2 true JPH0128043B2 (en) | 1989-05-31 |
Family
ID=15250727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13967280A Granted JPS5763301A (en) | 1980-10-06 | 1980-10-06 | Cellulose ether acidic succinoyl and acidic phthaloyl mixed ester |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5763301A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016148973A1 (en) * | 2015-03-16 | 2016-09-22 | Dow Global Technologies Llc | Water-soluble esterified cellulose ethers |
WO2016148978A1 (en) * | 2015-03-16 | 2016-09-22 | Dow Global Technologies Llc | Process for preparing an esterified cellulose ether in the presence of an aliphatic carboxylic acid |
WO2016148970A1 (en) * | 2015-03-16 | 2016-09-22 | Dow Global Technologies Llc | Aqueous solution of an esterified cellulose ether |
EP3270971B1 (en) * | 2015-03-16 | 2019-01-09 | Dow Global Technologies LLC | Water-soluble esterified cellulose ethers having a low degree of neutralization |
WO2016148976A1 (en) * | 2015-03-16 | 2016-09-22 | Dow Global Technologies Llc | Gelling esterified cellulose ethers |
WO2017065037A1 (en) * | 2015-10-16 | 2017-04-20 | コニカミノルタ株式会社 | Biocompatible resin |
-
1980
- 1980-10-06 JP JP13967280A patent/JPS5763301A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5763301A (en) | 1982-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4377568A (en) | Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same | |
US3629237A (en) | Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them | |
US3789117A (en) | Process for the preparation of enteric medicaments | |
JPS6281402A (en) | Production of acidic dicarboxylic acid ester of cellulose ether | |
US3957523A (en) | Coating compositions for solid medicines | |
EP0018605A2 (en) | Enterosoluble capsule and method for its preparation | |
JP2000500140A (en) | Cellulose acetate phthalate visceral coating composition | |
DE2841164A1 (en) | CELLULOSEAETHERESTER, METHOD OF MANUFACTURING AND USING THE SAME | |
US3940384A (en) | Methyl hydroxypropyl cellulose acetate and process | |
KR900005795B1 (en) | Process for coating solid pharma-ceutical preparations | |
JPS5951562B2 (en) | Method for producing acidic succinyl and aliphatic monoacyl mixed ester of cellulose ether | |
CA1165687A (en) | Medicament capsules for rectal application | |
JPH0128043B2 (en) | ||
US5700929A (en) | Base for coating solid enteric pharmaceutical preparations | |
US3086007A (en) | Water soluble cellulose acetate propionate sulfate salts and films thereof | |
US3712886A (en) | Method for preparing cellulose ether derivatives | |
US3870702A (en) | Cellulose ether compositions useful as enteric coatings | |
US2897122A (en) | Enteric coated product | |
US3022287A (en) | Method of preparing cellulose esters of trimellitic acid | |
JPS62266060A (en) | Production of medical hard capsule | |
JPH0371415B2 (en) | ||
JPS607492B2 (en) | enteric-coated capsules | |
DE2140996C3 (en) | Use of a cellulose ether ester in coating compositions for pharmaceutical products that act in the intestine | |
EP0041665B1 (en) | Medicament capsules for rectal application | |
JPS6355525B2 (en) |